Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-12-001406

Options or other derivatives

  • CFO, TREASURER AND SECRETARY acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Varvaro Thomas C · CFO, TREASURER AND SECRETARY

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-08-28 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +200,000 $0.64 2022-08-28 200,000 2,678,500 D
Loading xslF345X03/form4-09252012_020906.xml…